p53 and bcl-2 in Epithelial Ovarian Carcinoma: Their Value as Prognostic Indicators at a Median Follow-up of 60 Months

This publication has 20 references indexed in Scilit:

• Clinical Significance of Apoptosis-Related Factors p53, Mdm2, and Bcl-2 in Advanced Ovarian Cancer
  Journal of Clinical Oncology, 1999
• Cancer statistics, 1999
  CA: A Cancer Journal for Clinicians, 1999
• Global cancer statistics
  CA: A Cancer Journal for Clinicians, 1999
• p53 Mutations and Expression in Ovarian Cancers
  International Journal of Gynecological Pathology, 1999
• Lack of bcl-2 Persistence: An Independent Prognostic Indicator of Poor Prognosis in Endometrial Carcinoma
  Gynecologic Oncology, 1998
• bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up.
  Journal of Clinical Oncology, 1998
• Quantification of p53 in Epithelial Ovarian Cancer
  Gynecologic Oncology, 1997
• bcl-2 Expression, p53 Accumulation, and Apoptosis in Ovarian Carcinomas
  American Journal of Clinical Pathology, 1996
• Expression and prognostic significance of Bcl-2 in ovarian tumours
  British Journal of Cancer, 1995
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
  Nature, 1988